IL17A and esophageal squamous cell carcinoma: It has been reported that IL-17A can activate MMP-2 and MMP-9 through the ROS/NF-κB signaling pathway (74), while matrix metalloproteinases (MMPs) could catalyze the degradation of extracellular matrix and promote ESCC migration and metastasis (75, 76).